Laura H Jacobson Selected Research

Seizures (Absence Seizure)

1/2018

Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura H Jacobson Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 06/2011
7	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2013
3	Narcolepsy 01/2021 - 12/2013
3	Cataplexy 01/2021 - 12/2013
3	Hypothermia 04/2008 - 05/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 12/2013
2	Tauopathies 01/2022 - 01/2021
2	Amyloid Plaque 11/2018 - 06/2011
2	Dementia (Dementias) 11/2018 - 09/2015
2	Sleep Wake Disorders 10/2013 - 01/2013
2	Anxiety Disorders (Anxiety Disorder) 01/2010 - 04/2008
2	Ataxia (Dyssynergia) 12/2006 - 05/2005
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Weight Gain 11/2018
1	Body Weight (Weight, Body) 11/2018
1	Asymptomatic Diseases 11/2018
1	Anhedonia 01/2018
1	Drug Resistant Epilepsy 01/2018
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Substance-Related Disorders (Drug Abuse) 02/2016
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016
1	Neuroinflammatory Diseases 09/2015
1	Pain (Aches) 12/2013
1	Obesity 12/2013
1	Migraine Disorders (Migraine) 12/2013
1	Weight Loss (Weight Reduction) 12/2011
1	Amyloidosis 08/2009

Drug/Important Bio-Agent (IBA)

8	suvorexantIBA 01/2022 - 01/2013
7	Amyloid (Amyloid Fibrils)IBA 11/2018 - 06/2011
6	Orexin Receptor AntagonistsIBA 01/2021 - 01/2013
5	Orexin ReceptorsIBA 01/2022 - 01/2013
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
4	OrexinsIBA 01/2022 - 12/2013
3	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 01/2017
3	almorexantIBA 12/2013 - 01/2013
3	Baclofen FDA LinkGeneric 04/2008 - 05/2005
2	Zolpidem (Ambien)FDA LinkGeneric 01/2022 - 01/2021
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2021 - 02/2016
2	UmibecestatIBA 10/2021 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2016
2	Peptides (Polypeptides)IBA 01/2018 - 12/2013
2	MK-6096IBA 12/2013 - 01/2013
2	N- ((1- ((5- (4- fluorophenyl)- 2- methyl- 4- thiazolyl)carbonyl)- 2- piperidinyl)methyl)- 4- benzofurancarboxamideIBA 12/2013 - 01/2013
2	GABA-B Receptor AgonistsIBA 04/2008 - 12/2006
2	GABA-B ReceptorsIBA 04/2008 - 05/2005
1	lemborexantIBA 01/2022
1	daridorexantIBA 01/2022
1	BenzodiazepinesIBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 11/2018
1	Fluoxetine (Prozac)FDA LinkGeneric 11/2018
1	Peroxynitrous Acid (Peroxynitrite)IBA 11/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	VenomsIBA 01/2018
1	Voltage-Gated Sodium ChannelsIBA 01/2018
1	Nicotine FDA Link 01/2018
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2016
1	NB-360IBA 09/2015
1	EnzymesIBA 01/2012
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2011
1	CannabinoidsIBA 12/2011
1	AntibodiesIBA 06/2011
1	Stainless Steel (Steel, Stainless)IBA 08/2009
1	PrionsIBA 08/2009
1	N,N'- dicyclopentyl- 2- methylsulfanyl- 5- nitro- pyrimidine- 4,6- diamineIBA 04/2008
1	Anti-Anxiety Agents (Anxiolytics)IBA 04/2008
1	2,6- di- tert- butyl- 4- (3- hydroxy- 2,2- dimethylpropyl)phenolIBA 04/2008
1	gamma-Aminobutyric Acid (GABA)IBA 12/2006

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2010
1	Intraventricular Infusions 01/2018
1	Precision Medicine 01/2018
1	Immunotherapy 01/2016
1	Traction 04/2008